Literature DB >> 10393966

HIV-1 Nef increases T cell activation in a stimulus-dependent manner.

J A Schrager1, J W Marsh.   

Abstract

Lentiviral Nef increases viral replication in vivo, plays a direct role in pathogenesis, and increases viral particle infectivity. We now find that HIV Nef also increases the activation of T cells, a cellular state required for optimal viral replication. This enhancement is stimulant-dependent. As defined by IL-2 generation, activation of T cells stimulated with classical mitogens [phorbol 12-myristate 13-acetate (PMA) + anti-CD3, PMA + phytohemagglutinin, and PMA + ionomycin] is unaffected by the expression of Nef. However, Nef increases IL-2 secretion when cells are stimulated through the T cell receptor and the costimulus receptor (CD28). This increase in activation, which depends on Nef myristylation, is caused by an increase in the number of cells reaching full activation and not by an increase in the amount of IL-2 secreted per cell. These findings demonstrate that Nef lowers the threshold of the dual-receptor T cell activation pathway. The capacity of Nef to increase T cell activity may be very important in vivo when Nef is the predominant or the only viral gene product expressed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10393966      PMCID: PMC22206          DOI: 10.1073/pnas.96.14.8167

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  57 in total

1.  A role for natural simian immunodeficiency virus and human immunodeficiency virus type 1 nef alleles in lymphocyte activation.

Authors:  L Alexander; Z Du; M Rosenzweig; J U Jung; R C Desrosiers
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

2.  Separable functions of Nef disrupt two aspects of T cell receptor machinery: CD4 expression and CD3 signaling.

Authors:  A J Iafrate; S Bronson; J Skowronski
Journal:  EMBO J       Date:  1997-02-17       Impact factor: 11.598

Review 3.  Biosynthetic retrovectoring systems for gene therapy.

Authors:  C P Hodgson; G Xu; F Solaiman; M A Zink
Journal:  J Mol Med (Berl)       Date:  1997-04       Impact factor: 4.599

4.  Calcium ionophore-treated peripheral blood monocytes and dendritic cells rapidly display characteristics of activated dendritic cells.

Authors:  B J Czerniecki; C Carter; L Rivoltini; G K Koski; H I Kim; D E Weng; J G Roros; Y M Hijazi; S Xu; S A Rosenberg; P A Cohen
Journal:  J Immunol       Date:  1997-10-15       Impact factor: 5.422

5.  Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy.

Authors:  D Finzi; M Hermankova; T Pierson; L M Carruth; C Buck; R E Chaisson; T C Quinn; K Chadwick; J Margolick; R Brookmeyer; J Gallant; M Markowitz; D D Ho; D D Richman; R F Siliciano
Journal:  Science       Date:  1997-11-14       Impact factor: 47.728

6.  A cytoplasmic inhibitor of the JNK signal transduction pathway.

Authors:  M Dickens; J S Rogers; J Cavanagh; A Raitano; Z Xia; J R Halpern; M E Greenberg; C L Sawyers; R J Davis
Journal:  Science       Date:  1997-08-01       Impact factor: 47.728

7.  Human immunodeficiency virus type 1 Nef does not alter T-cell sensitivity to antigen-specific stimulation.

Authors:  K A Page; W C van Schooten; M B Feinberg
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

8.  Nef association with human immunodeficiency virus type 1 virions and cleavage by the viral protease.

Authors:  A A Bukovsky; T Dorfman; A Weimann; H G Göttlinger
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

9.  Establishment of a stable, inducible form of human immunodeficiency virus type 1 DNA in quiescent CD4 lymphocytes in vitro.

Authors:  C A Spina; J C Guatelli; D D Richman
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

10.  Recovery of replication-competent HIV despite prolonged suppression of plasma viremia.

Authors:  J K Wong; M Hezareh; H F Günthard; D V Havlir; C C Ignacio; C A Spina; D D Richman
Journal:  Science       Date:  1997-11-14       Impact factor: 47.728

View more
  86 in total

1.  Mechanism for down-regulation of CD28 by Nef.

Authors:  T Swigut; N Shohdy; J Skowronski
Journal:  EMBO J       Date:  2001-04-02       Impact factor: 11.598

2.  The Nef protein of HIV-1 associates with rafts and primes T cells for activation.

Authors:  J K Wang; E Kiyokawa; E Verdin; D Trono
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

3.  Disrupting surfaces of nef required for downregulation of CD4 and for enhancement of virion infectivity attenuates simian immunodeficiency virus replication in vivo.

Authors:  A J Iafrate; S Carl; S Bronson; C Stahl-Hennig; T Swigut; J Skowronski; F Kirchhoff
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

4.  Nef enhances human immunodeficiency virus type 1 infectivity in the absence of matrix.

Authors:  Tatyana Dorfman; Elena Popova; Massimo Pizzato; Heinrich G Göttlinger
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

Review 5.  HIV-1 Nef control of cell signalling molecules: multiple strategies to promote virus replication.

Authors:  Alison L Greenway; Gavan Holloway; Dale A McPhee; Phoebe Ellis; Alyssa Cornall; Michael Lidman
Journal:  J Biosci       Date:  2003-04       Impact factor: 1.826

6.  Counteraction of HLA-C-mediated immune control of HIV-1 by Nef.

Authors:  Anke Specht; Amalio Telenti; Raquel Martinez; Jacques Fellay; Elizabeth Bailes; David T Evans; Mary Carrington; Beatrice H Hahn; David B Goldstein; Frank Kirchhoff
Journal:  J Virol       Date:  2010-05-12       Impact factor: 5.103

7.  Down-modulation of mature major histocompatibility complex class II and up-regulation of invariant chain cell surface expression are well-conserved functions of human and simian immunodeficiency virus nef alleles.

Authors:  Michael Schindler; Stephanie Würfl; Philippe Benaroch; Thomas C Greenough; Rod Daniels; Philippa Easterbrook; Matthias Brenner; Jan Münch; Frank Kirchhoff
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

8.  Early transcription from nonintegrated DNA in human immunodeficiency virus infection.

Authors:  Yuntao Wu; Jon W Marsh
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

9.  Human T-cell lymphotropic virus type 1 p12I enhances interleukin-2 production during T-cell activation.

Authors:  Wei Ding; Seung-Jae Kim; Amrithraj M Nair; Bindhu Michael; Kathleen Boris-Lawrie; Adam Tripp; Gerold Feuer; Michael D Lairmore
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

10.  Tat controls transcriptional persistence of unintegrated HIV genome in primary human macrophages.

Authors:  Beatrix Meltzer; Deemah Dabbagh; Jia Guo; Fatah Kashanchi; Mudit Tyagi; Yuntao Wu
Journal:  Virology       Date:  2018-03-15       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.